FOLH1 and neoplasm: A SPION-based radiotheranostic system combined PSMA-617 targeting with 44Sc/47Sc chelation, enabling PET/MRI imaging and radiotherapy, and achieved significant therapeutic efficacy in PSMA-positive LNCaP cells and 3D tumor spheroids [147].